FDA Inspection
Ulhas M. Nadgir, M.D.Ulhas M. Nadgir, M.D. – FDA Inspection, Oct 10, 2024
Record Details
This FDA Inspection record concerns Ulhas M. Nadgir, M.D., with an inspection on October 10, 2024, issued by the San Francisco District Office, covering human drugs.
View Company Profile
ID · d684c021-e768-488f-8840-70d3fa4346a9
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1251475
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring: Human Drugs
FDA Citations
1- 21 CFR 312.60FD-1572, protocol compliance
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.